Veterinary antibiotics constitute a category of animal medications designed to combat infectious diseases in animals. They achieve this by eliminating microorganisms such as bacteria and parasites, hindering the growth of their cell walls to effectively combat infections and diseases in animals, thereby enhancing the health conditions of the animals.
The primary product types within veterinary antibiotics encompass anti-parasitic drugs, anti-bacterial medications, non-steroidal anti-inflammatory drugs (NSAIDs), and other related products. NSAIDs serve as a connection point between the production and activity of prostaglandins (enzymes) involved in inflammation. Approved veterinary NSAIDs find application in companion animal care, specifically in mitigating pain and swelling associated with osteoarthritis in dogs and horses. The administration of veterinary antibiotics includes various methods such as premixes, injections, oral powders, oral solutions, and other forms, catering to both farm animals and companion animals.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The rapid escalation of U.S. tariffs and the resulting trade tensions in spring 2025 are having a considerable impact on the veterinary healthcare sector, particularly in the supply of pharmaceuticals, medical devices, and animal care products. Increased duties on imported veterinary medicines, diagnostic equipment, surgical tools, and pet care supplies have driven up operational costs for veterinary clinics, animal hospitals, and livestock health providers, forcing them to either raise service charges or absorb reduced profit margins. The livestock and agricultural industries are facing similar pressures, as tariffs on feed additives, vaccines, and breeding equipment push up production costs and complicate animal health management. Furthermore, retaliatory tariffs in major export markets have weakened demand for U.S.-manufactured veterinary products, adding to revenue challenges. To navigate these headwinds, the sector must now focus on local sourcing, preventive healthcare strategies, and digital veterinary solutions to control costs while continuing to deliver quality animal care.
The veterinary antibiotics research report is one of a series of new reports from The Business Research Company that provides veterinary antibiotics statistics, including veterinary antibiotics industry global market size, regional shares, competitors with veterinary antibiotics share, detailed veterinary antibiotics segments, market trends and opportunities, and any further data you may need to thrive in the veterinary antibiotics industry. The veterinary antibiotics research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The veterinary antibiotics market size has grown strongly in recent years. It will grow from $2.15 billion in 2024 to $2.34 billion in 2025 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to increased pet spending and shortages of generic medicines.
The veterinary antibiotics market size is expected to see strong growth in the next few years. It will grow to $3.22 billion in 2029 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to increasing penetration of pet insurance, rise in pet ownership, increase in government initiatives, and growing awareness about animal health. Major trends in the forecast period include strategic collaborations and partnerships, development of new chewable medicines, combination parasiticides, new improved treatments for arthritis and production of generic drugs for animal care.
The forecast of 8.3% growth over the next five years remains unchanged from the previous projection for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Import barriers on active ingredients and processing chemicals may disrupt antibiotic production, affecting supply and increasing prices across the veterinary sector. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The veterinary antibiotics market is experiencing growth due to an increase in the prevalence of zoonotic diseases. Zoonotic diseases are infectious conditions caused by microorganisms, infections, and parasites that can be transmitted between animals and humans. Common zoonotic pathogens such as salmonella and campylobacter, found in the intestines of animals, pose a potential threat to humans through the food chain. A study by FoodNet (Centers for Disease Control and Prevention, USA) revealed that zoonotic diseases cause 24,484 foodborne illnesses, 5,677 hospitalizations, and 122 deaths. The need for early diagnosis in animals to prevent the transmission of these diseases to humans is a significant driver of the veterinary antibiotics market.
The increasing rate of pet ownership is anticipated to drive the growth of the veterinary antibiotics market in the coming years. Pet ownership refers to the legally recognized and responsible practice of caring for domesticated animals as companions, which includes addressing their physical, emotional, and medical needs. As the number of pets grows, the demand for antibiotics to treat and prevent illnesses in pets is also expected to rise, creating a larger patient base that requires veterinary care, including antibiotics, to ensure their health and well-being. For example, as of October 2024, the American Veterinary Medical Association (a nonprofit professional association) reported that the total number of dog-owning households in the U.S. is projected to reach 59.8 million, representing 45.5% of all U.S. households. Similarly, the number of cat-owning households has increased to 42.1 million, accounting for 32.1% of all U.S. households. Consequently, the rise in pet ownership is fueling the expansion of the veterinary antibiotics market.
An emerging trend in the veterinary antibiotics market is the increasing collaboration between companies. Collaboration allows companies to combine technologies, diversify their product range, and enhance the quality and speed of antibiotic production. Notably, GlobalVetLink, a US-based provider of software services, collaborated with Veterinary Innovative Partners to implement the GlobalVetLink Compliance Assistant, a comprehensive SaaS platform simplifying animal health.
Major players in the veterinary antibiotics market are gaining a competitive edge by developing telemedicine platforms for pet healthcare. Telemedicine involves remote diagnosis, consultation, treatment, and monitoring of patients using telecommunications technology. Cargill Inc., a US-based food corporation, launched Zoonivet, a digital pet-care app in June 2023, facilitating pet healthcare through video calls, with plans to offer surgery, home diagnostic services, medication, pet food, and boarding in key Indian markets.
The veterinary antibiotics prescription drugs market operates under the regulatory framework of Section 503(f) of the Food, Drug, and Cosmetic Act by the FDA. This regulation mandates cautionary statements on veterinary antibiotic drug labels, emphasizing that these drugs can only be used with the permission of a licensed veterinarian. Stricter actions are taken against the sale and use of antibiotic prescription drugs without proper authorization, ensuring compliance with regulations governing veterinary antibiotic manufacturers and sellers.
Major companies operating in the veterinary antibiotics market include Boehringer Ingelheim GmbH, Zoetis, Inc., Merck & Co., Inc., Elanco Animal Health Incorporated, Vetoquinol S.A., Phibro Animal Health Corporation, Kyoritsu Seiyaku Corporation, Dechra Pharmaceuticals plc, Bayer Animal Health China, China Animal Healthcare Ltd., China Animal Husbandry Industry Corporation Ltd. (CAHIC), Guangdong Wens Dahuanong Biotechnology Co. Ltd., IDEXX Laboratories, Merial Pulike Biological Engineering, Ceva Sante Animale, Nimrod Veterinary Products Ltd., Bimeda, VIRBAC SA, Orion Animal Health, Laboratorios Calier, SA, Petmedix, Eco Animal Health, Teknofarma, Farmavet, Candioli Pharma, Suanfarma, Marino Ibericamed, MPA veterinary, Lamons Laboratories SA, SUPER'S DIANA, Swetrade Pharmaceuticals AB, Animalcare, VIC Animal Health, AVZ animal health, Provet Group, VitOMEK LCC, Micro-plus, Biowet, Bioveta, Brovapharma, Evrovet, Ukrvetprompostach, VELELEK d.o.o, Veterinarski Zavod Subotica, VetPlanet, Delos Medica, Vetro Solutions, Belfarmacom, IDT Biologika, UCBVET, Syntec, Sauvet, Vetanco, Chemo Argentina, Brouwer, Agrovet Market Animal Health, Lemavet, Saudi Pharmaceutical Industries (SPI), DBK Pharma S.A.E.
North America was the largest region in the veterinary antibiotics market in 2024. Asia-Pacific was the second-largest region in the global veterinary antibiotics market share. The regions covered in the veterinary antibiotics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the veterinary antibiotics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain
The veterinary antibiotics market consists of sales of antivirals, antiprotozoals, antifungals, aminoglycosides, beta-lactams, fluoroquinolones, glycopeptides, and lipopeptides. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Veterinary Antibiotics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on veterinary antibiotics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for veterinary antibiotics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The veterinary antibiotics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Product: Anti-parasitic, Anti-bacterial, Non-steroidal anti-inflammatory drug, Others
- 2) By End User: Farm Animals, Companion Animals
- 3) By Administration: Premixes, Injections, Oral Powders, Oral Solutions, Others
- Subsegments:
- 1) Anti-Parasitic: Endoparasiticides; Ectoparasiticides
- 2) Anti-Bacterial: Tetracyclines; Penicillins; Macrolides; Aminoglycosides; Sulfonamides
- 3) Non-Steroidal Anti-Inflammatory Drug (Nsaid): Carprofen; Meloxicam; Aspirin
- 4) Others: Antifungal; Antiviral
- Companies Mentioned: Boehringer Ingelheim GmbH; Zoetis, Inc.; Merck & Co., Inc.; Elanco Animal Health Incorporated; Vetoquinol S.A.; Phibro Animal Health Corporation; Kyoritsu Seiyaku Corporation; Dechra Pharmaceuticals plc; Bayer Animal Health China; China Animal Healthcare Ltd.; China Animal Husbandry Industry Corporation Ltd. (CAHIC); Guangdong Wens Dahuanong Biotechnology Co. Ltd.; IDEXX Laboratories; Merial Pulike Biological Engineering; Ceva Sante Animale; Nimrod Veterinary Products Ltd.; Bimeda; VIRBAC SA; Orion Animal Health; Laboratorios Calier, SA; Petmedix; Eco Animal Health; Teknofarma; Farmavet; Candioli Pharma; Suanfarma; Marino Ibericamed; MPA veterinary; Lamons Laboratories SA; SUPER'S DIANA; Swetrade Pharmaceuticals AB; Animalcare; VIC Animal Health; AVZ animal health; Provet Group; VitOMEK LCC; Micro-plus; Biowet; Bioveta; Brovapharma; Evrovet; Ukrvetprompostach; VELELEK d.o.o; Veterinarski Zavod Subotica; VetPlanet; Delos Medica; Vetro Solutions; Belfarmacom; IDT Biologika; UCBVET; Syntec; Sauvet; Vetanco; Chemo Argentina; Brouwer; Agrovet Market Animal Health; Lemavet; Saudi Pharmaceutical Industries (SPI); DBK Pharma S.A.E.
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time Series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Veterinary Antibiotics Market Characteristics
3. Veterinary Antibiotics Market Trends And Strategies
4. Veterinary Antibiotics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
- 4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Veterinary Antibiotics Growth Analysis And Strategic Analysis Framework
- 5.1. Global Veterinary Antibiotics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Veterinary Antibiotics Market Growth Rate Analysis
- 5.4. Global Veterinary Antibiotics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Veterinary Antibiotics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Veterinary Antibiotics Total Addressable Market (TAM)
6. Veterinary Antibiotics Market Segmentation
- 6.1. Global Veterinary Antibiotics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Anti-Parasitic
- Anti-Bacterial
- Non-Steroidal Anti-Inflammatory Drug
- Other Products
- 6.2. Global Veterinary Antibiotics Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Premixes
- Injections
- Oral Powders
- Oral Solutions
- Other Admisnistration
- 6.3. Global Veterinary Antibiotics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Farm Animals
- Companion Animals
- 6.4. Global Veterinary Antibiotics Market, Sub-Segmentation Of Anti-parasitic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Endoparasiticides
- Ectoparasiticides
- 6.5. Global Veterinary Antibiotics Market, Sub-Segmentation Of Anti-bacterial, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Tetracyclines
- Penicillins
- Macrolides
- Aminoglycosides
- Sulfonamides
- 6.6. Global Veterinary Antibiotics Market, Sub-Segmentation Of Non-steroidal Anti-inflammatory Drug (NSAID), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Carprofen
- Meloxicam
- Aspirin
- 6.7. Global Veterinary Antibiotics Market, Sub-Segmentation Of Others, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Antifungal
- Antiviral
7. Veterinary Antibiotics Market Regional And Country Analysis
- 7.1. Global Veterinary Antibiotics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Veterinary Antibiotics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Veterinary Antibiotics Market
- 8.1. Asia-Pacific Veterinary Antibiotics Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Veterinary Antibiotics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Veterinary Antibiotics Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Veterinary Antibiotics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Veterinary Antibiotics Market
- 9.1. China Veterinary Antibiotics Market Overview
- 9.2. China Veterinary Antibiotics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Veterinary Antibiotics Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Veterinary Antibiotics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Veterinary Antibiotics Market
- 10.1. India Veterinary Antibiotics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Veterinary Antibiotics Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Veterinary Antibiotics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Veterinary Antibiotics Market
- 11.1. Japan Veterinary Antibiotics Market Overview
- 11.2. Japan Veterinary Antibiotics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Veterinary Antibiotics Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Veterinary Antibiotics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Veterinary Antibiotics Market
- 12.1. Australia Veterinary Antibiotics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Veterinary Antibiotics Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Veterinary Antibiotics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Veterinary Antibiotics Market
- 13.1. Indonesia Veterinary Antibiotics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Veterinary Antibiotics Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Veterinary Antibiotics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Veterinary Antibiotics Market
- 14.1. South Korea Veterinary Antibiotics Market Overview
- 14.2. South Korea Veterinary Antibiotics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Veterinary Antibiotics Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Veterinary Antibiotics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Veterinary Antibiotics Market
- 15.1. Western Europe Veterinary Antibiotics Market Overview
- 15.2. Western Europe Veterinary Antibiotics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Veterinary Antibiotics Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Veterinary Antibiotics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Veterinary Antibiotics Market
- 16.1. UK Veterinary Antibiotics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Veterinary Antibiotics Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Veterinary Antibiotics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Veterinary Antibiotics Market
- 17.1. Germany Veterinary Antibiotics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Veterinary Antibiotics Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Veterinary Antibiotics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Veterinary Antibiotics Market
- 18.1. France Veterinary Antibiotics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Veterinary Antibiotics Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Veterinary Antibiotics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Veterinary Antibiotics Market
- 19.1. Italy Veterinary Antibiotics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Veterinary Antibiotics Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Veterinary Antibiotics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Veterinary Antibiotics Market
- 20.1. Spain Veterinary Antibiotics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Veterinary Antibiotics Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Veterinary Antibiotics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Veterinary Antibiotics Market
- 21.1. Eastern Europe Veterinary Antibiotics Market Overview
- 21.2. Eastern Europe Veterinary Antibiotics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Veterinary Antibiotics Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Veterinary Antibiotics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Veterinary Antibiotics Market
- 22.1. Russia Veterinary Antibiotics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Veterinary Antibiotics Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Veterinary Antibiotics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Veterinary Antibiotics Market
- 23.1. North America Veterinary Antibiotics Market Overview
- 23.2. North America Veterinary Antibiotics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Veterinary Antibiotics Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Veterinary Antibiotics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Veterinary Antibiotics Market
- 24.1. USA Veterinary Antibiotics Market Overview
- 24.2. USA Veterinary Antibiotics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Veterinary Antibiotics Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Veterinary Antibiotics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Veterinary Antibiotics Market
- 25.1. Canada Veterinary Antibiotics Market Overview
- 25.2. Canada Veterinary Antibiotics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Veterinary Antibiotics Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Veterinary Antibiotics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Veterinary Antibiotics Market
- 26.1. South America Veterinary Antibiotics Market Overview
- 26.2. South America Veterinary Antibiotics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Veterinary Antibiotics Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Veterinary Antibiotics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Veterinary Antibiotics Market
- 27.1. Brazil Veterinary Antibiotics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Veterinary Antibiotics Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Veterinary Antibiotics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Veterinary Antibiotics Market
- 28.1. Middle East Veterinary Antibiotics Market Overview
- 28.2. Middle East Veterinary Antibiotics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Veterinary Antibiotics Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Veterinary Antibiotics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Veterinary Antibiotics Market
- 29.1. Africa Veterinary Antibiotics Market Overview
- 29.2. Africa Veterinary Antibiotics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Veterinary Antibiotics Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Veterinary Antibiotics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Veterinary Antibiotics Market Competitive Landscape And Company Profiles
- 30.1. Veterinary Antibiotics Market Competitive Landscape
- 30.2. Veterinary Antibiotics Market Company Profiles
- 30.2.1. Boehringer Ingelheim GmbH Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Zoetis, Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Merck & Co., Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Elanco Animal Health Incorporated Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Vetoquinol S.A. Overview, Products and Services, Strategy and Financial Analysis
31. Veterinary Antibiotics Market Other Major And Innovative Companies
- 31.1. Phibro Animal Health Corporation
- 31.2. Kyoritsu Seiyaku Corporation
- 31.3. Dechra Pharmaceuticals plc
- 31.4. Bayer Animal Health China
- 31.5. China Animal Healthcare Ltd.
- 31.6. China Animal Husbandry Industry Corporation Ltd. (CAHIC)
- 31.7. Guangdong Wens Dahuanong Biotechnology Co. Ltd.
- 31.8. IDEXX Laboratories
- 31.9. Merial Pulike Biological Engineering
- 31.10. Ceva Sante Animale
- 31.11. Nimrod Veterinary Products Ltd.
- 31.12. Bimeda
- 31.13. VIRBAC SA
- 31.14. Orion Animal Health
- 31.15. Laboratorios Calier, SA
32. Global Veterinary Antibiotics Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Veterinary Antibiotics Market
34. Recent Developments In The Veterinary Antibiotics Market
35. Veterinary Antibiotics Market High Potential Countries, Segments and Strategies
- 35.1 Veterinary Antibiotics Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Veterinary Antibiotics Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Veterinary Antibiotics Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
